Available Actions:
Edit Permissions
Remove Shortcut from dashboard

MAx Scorecard

Country Price National Access Determination Regional HTAs Local Forumlary Status List Price Secured vs Forecasted Avg Level of Discounts
UK £800 Positive Guidance N/A 100% 0%
FR $1000 SMR Important;
ASMR IV		 N/A 80% 10%
ES $1000 Access approved only for sub-populations and with restrictions in several regions Region 1: YYY;
Region 2: YYY;		 100% 20%
IT $1000 Full label but use requires pharmacist approval in majority of hospitals
DE $1000 Unquantifiable Benefit N/A 100% 10%